1-2 of 2
Ankesh Jaiswal
Close
Sort by
Journal Articles

Making Anti-CD19 CAR-T Cell Therapy Accessible and Affordable: First-in-Human Phase I Clinical Trial Experience from India

Atharva Karulkar, Hasmukh Jain, Shreshtha Shah, Aalia Khan, Ankesh Jaiswal, Afrin Firfiray, Prashant Suvasia, Priyanshi Suvasia, Juber Pendhari, Sweety Asija, Ambalika Chowdury, Ankit Banik, Smrithi Ravikumar, Neha Sharma, Minal Poojary, Sumathi Hiregoudar, Preeti Desai, Anisha Navkudkar, Sunil Rajadhyaksha, Jayashree Thorat, Prashant R. Tembhare, Albeena Nisar, Manju Sengar, David F. Stroncek, Steven Highfill, Nirali N. Shah, Gaurav Narula, Rahul Purwar
Journal: Blood
Blood (2022) 140 (Supplement 1): 4610–4611.
https://doi.org/10.1182/blood-2022-168928
Published: 2022
Journal Articles

Phase I Trial of Humanized CD19 CART-Cell Therapy Developed in India: Safe, Active and Feasible for Outpatient Therapy

Hasmukh Jain, Atharva Karulkar, Neha Sharma, Manju Sengar, Ankesh Jaiswal, Shreshtha Shah, Aalia Khan, Afrin Firfiray, Sweety Asija, Prashant Suvasia, Priyanshi Suvasia, Juber Pendhari, Devanshi Kalra, Smrithi Ravikumar, Gaurav Narula, Shripad Banavali, Minal Poojary, Sumathi Hiregoudar, Lingaraj Nayak, Bhausaheb Bagal, Prashant R. Tembhare, Sridhar Epari, Navin Khattry, Nikhil Patkar, Sumeet Gujral, Tanuja Shet, Papagudi Ganesan Subramanian, Jayashree Thorat, Sachin Punatar, Anant Gokarn, Kinjalka Ghosh, Archi Agarwal, Preeti Desai, Shashank Ojha, Subhash Yadav, Shil Pushp Bhosale, Sunil Rajadhyaksha, Anisha Navkudkar, Siddharth Laskar, Sumeet Prakash Mirgh, Albeena Nisar, Deepali Pandit, Ruchira Patil, Rahul Purwar, Sattva S. Neelapu, Nirali N. Shah
Journal: Blood
Blood (2022) 140 (Supplement 1): 10332–10334.
https://doi.org/10.1182/blood-2022-166082
Published: 2022